Literature DB >> 7252163

Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique.

C G Figdor, W S Bont, J E De Vries, W L Van Es.   

Abstract

A modified centrifugal elutriation technique is described for the isolation of large numbers of lymphocytes and monocytes. Elutriation was carried out by lowering the rotor speed at a constant flow rate which was generated by hydrostatic pressure. The flow rate could be kept constant if the separation procedure was performed at high pressure and high systemic resistance. Up to 2.3 X 10(9) mononuclear cells derived from 2000 ml blood were separated in one single experiment in approximately 1 h. The lymphocytes and monocytes were isolated at purities of 98 +/- 1% and 94 +/- 1% respectively. The purity of the lymphocytes was increased to 99.8 +/- 0.1% by a second elutriation run. Additional advantages of the elutriation procedures are that the choice of medium is free, and that relatively large numbers of cells may be separated with high recoveries.

Mesh:

Year:  1981        PMID: 7252163     DOI: 10.1016/0022-1759(81)90359-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Effect of aniosmotic media on the volume of the T-lymphocyte nucleus.

Authors:  A G Hoekstra; J A Aten; P M Sloot
Journal:  Biophys J       Date:  1991-04       Impact factor: 4.033

2.  Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molecule-1.

Authors:  M Lub; Y van Kooyk; S J van Vliet; C G Figdor
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

3.  A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.

Authors:  B G Bolscher; R van Zwieten; I M Kramer; R S Weening; A J Verhoeven; D Roos
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway.

Authors:  T van der Bruggen; S Nijenhuis; E van Raaij; J Verhoef; B S van Asbeck
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alpha.

Authors:  W M Vuist; M J Visseren; M Otsen; K Bos; F A Vyth-Dreese; C G Figdor; C J Melief; A Hekman
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

6.  Alteration of Fc-receptor phenotype and proliferative capacity of Fc-IgG-receptor positive lymphocytes through interaction with soluble immune complexes of patients with SLE or RA.

Authors:  M Thien; D Renger; H Deicher; W J Pichler
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

7.  Regulatory effect of interleukin-4 (IL-4) on the expression and function of lymphocyte adhesion receptors involved in IL-2-induced cell aggregation.

Authors:  F A Vyth-Dreese; Y Van Kooyk; T A Dellemijn; C J Melief; C G Figdor
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

8.  Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.

Authors:  R S Weening; L Corbeel; M de Boer; R Lutter; R van Zwieten; M N Hamers; D Roos
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

9.  Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.

Authors:  G C Mudde; D van Dam; G C De Gast
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes.

Authors:  M Baggiolini; P Mauderli; U Näf; B Catanese
Journal:  Agents Actions       Date:  1985-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.